Page 11 - Codexis Inc News Today

Pharmaceutical Intermediates are a class of chemical compounds used as key components in the manufacturing of drugs, bridging the gap between raw materials and the final formulation of medicines. They play a vital role in the pharmaceutical industry by offering efficient and cost-effective solutions for drug synthes...

StockNews.com lowered shares of Codexis (NASDAQ:CDXS – Free Report) from a hold rating to a sell rating in a research report sent to investors on Friday morning. A number of other research analysts have also recently commented on the stock. Stephens reissued an overweight rating and issued a $6.00 target price on shares of Codexis […]

Equities Research Analysts’ downgrades for Friday, July 21st: Banner (NASDAQ:BANR) was downgraded by analysts at StockNews.com from a hold rating to a sell rating. Codexis (NASDAQ:CDXS) was downgraded by analysts at StockNews.com from a hold rating to a sell rating. CEMEX (NYSE:CX) was downgraded by analysts at StockNews.com from a strong-buy rating to a buy […]

Research Analysts’ updated eps estimates for Friday, July 21st: Abbott Laboratories (NYSE:ABT) had its equal weight rating reaffirmed by analysts at Morgan Stanley. Morgan Stanley currently has a $112.00 target price on the stock. AdTheorent (NASDAQ:ADTH) had its buy rating reiterated by analysts at Needham & Company LLC. The firm currently has a $3.00 price […]

Codexis Inc (NASDAQ: CDXS) intends to prioritize advancing and commercializing its Enzyme-Catalyzed Oligonucleotide (ECO) Synthesis platform and its 

Codexis Inc CDXS intends to prioritize advancing and commercializing its Enzyme-Catalyzed Oligonucleotide (ECO) Synthesis platform and its Pharmaceutical…

Rare orphan indication Givosiran - rare orphan indication Lumasiran - rare orphan indication ...

We engineer enzymes Corporate Presentation July 2023 ...